Urodynamic assessment and proteomic analysis of lower urinary tract dysfunction following nerve-sparing radical hysterectomy
- PMID: 40181139
- PMCID: PMC11968810
- DOI: 10.1038/s41598-025-96496-4
Urodynamic assessment and proteomic analysis of lower urinary tract dysfunction following nerve-sparing radical hysterectomy
Abstract
This study aimed to evaluate lower urinary tract dysfunction after radical hysterectomy using urodynamic studies and to identify urinary biomarkers for detrusor underactivity via proteomic analysis. This prospective single-center study included women who underwent nerve-sparing radical hysterectomy for cervical carcinoma. Preoperative and postoperative assessments (at 1 and 6 months) included the International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score, urethral pressure profiling, and pressure flow studies. Detrusor contractility was assessed using the projected isovolumetric pressure (PIP1). Proteomic analysis was performed to identify urinary biomarkers associated with postoperative detrusor underactivity. Twenty-five patients were included. The total IPSS increased significantly at 1 and 6 months postoperatively. The maximum urethral closure pressure decreased significantly at 1 month and stabilized thereafter. PIP1 and voiding efficiency decreased significantly at 1 month, but improved by 6 months. Proteomic analysis revealed significant correlations between the changes in urinary ezrin, moesin, transthyretin, and PIP1 levels. Receiver operating characteristic analysis identified the optimal cutoff values for these biomarkers in diagnosing detrusor underactivity (PIP1 < 30). It was concluded that nerve-sparing radical hysterectomy impairs detrusor contractility and urethral function. Additionally, urinary ezrin, moesin, and transthyretin levels may be valuable biomarkers for diagnosing detrusor underactivity.
Keywords: Biomarkers; Hysterectomy; Underactive; Urinary bladder; Urodynamics.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Disclosure: This study followed the principles outlined in the Declaration of Helsinki and was approved by the ethics committee of our institution (Institutional Review Board approval No. 2016 − 0199). Written informed consent was obtained from all participants before enrollment. Trial registration number: UMIN000022369. The date of the first registration was 20/05/2016. The authors declare no conflicts of interest.
Figures
References
-
- Abrams, P. et al. The standardisation of terminology of lower urinary tract function: report from the standardisation Sub-Committee of the international continence society. Neurourol. Urodyn.21, 167–178. 10.1002/nau.10052 (2002). - PubMed
-
- Plotti, F. et al. Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer. Crit. Rev. Oncol. Hematol.80, 323–329. 10.1016/j.critrevonc.2010.12.004 (2011). - PubMed
-
- Zullo, M. A., Manci, N., Angioli, R., Muzii, L. & Panici, P. B. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit. Rev. Oncol. Hematol.48, 287–293. 10.1016/s1040-8428(03)00125-2 (2003). - PubMed
-
- Krishnan, A. et al. Urinary adenosine triphosphate and nitric oxide levels in patients with underactive bladder: a preliminary study. World J. Urol.39, 4421–4425. 10.1007/s00345-021-03784-5 (2021). - PubMed
-
- Chen, S. F., Jiang, Y. H. & Kuo, H. C. Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery. Int. Urol. Nephrol.49, 1763–1770. 10.1007/s11255-017-1666-z (2017). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
